Canada - Engels - Health Canada

apotex inc - cefaclor - powder - 250mg - cefaclor 250mg - second generation cephalosporins

Canada - Engels - Health Canada

apotex inc - cefaclor - powder - 375mg - cefaclor 375mg - second generation cephalosporins

Canada - Engels - Health Canada

teva canada limited - cefaclor - capsule - 250mg - cefaclor 250mg - second generation cephalosporins

Canada - Engels - Health Canada

teva canada limited - cefaclor - capsule - 500mg - cefaclor 500mg - second generation cephalosporins

Verenigde Staten - Engels - NLM (National Library of Medicine)

jazeera pharmaceutical - cefaclor (unii: 69k7k19h4l) (cefaclor anhydrous - unii:3z6fs3ik0k) - cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: otitis media caused by streptococcus pneumoniae , haemophilus influenzae , staphylococci, and streptococcus pyogenes   lower respiratory tract infections , including pneumonia caused by streptococcus pneumoniae , haemophilus influenzae, and streptococcus pyogenes   pharyngitis and tonsillitis , caused by streptococcus pyogenes   note : penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefaclor is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections , including pyelonephritis and cystitis, caused by escherichia coli, proteus mirabilis, klebsiella spp., and coagulase-negative staphylococci skin

Verenigde Staten - Engels - NLM (National Library of Medicine)

hikma pharmaceutical - cefaclor (unii: 69k7k19h4l) (cefaclor anhydrous - unii:3z6fs3ik0k) - cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: otitis media caused by streptococcus pneumoniae , haemophilus influenzae , staphylococci, and streptococcus pyogenes lower respiratory tract infections , including pneumonia caused by streptococcus pneumoniae , haemophilus influenzae , and streptococcus pyogenes pharyngitis and tonsillitis , caused by streptococcus pyogenes note: penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefaclor is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections , including pyelonephritis and cystitis, caused by escherichia coli , proteus mirabilis , klebsiella spp., and coagulase-negative staphylococci skin an

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

viatris limited - cefaclor monohydrate 26.22 mg/ml equivalent to cefaclor 25 mg/ml - granules for oral suspension - 125 mg/5ml - active: cefaclor monohydrate 26.22 mg/ml equivalent to cefaclor 25 mg/ml excipient: mannitol simeticone sodium laurilsulfate sorbitol xanthan gum

Nieuw-Zeeland - Engels - Medsafe (Medicines Safety Authority)

viatris limited - cefaclor monohydrate 52.45 mg/ml equivalent to cefaclor 50 mg/ml - granules for oral suspension - 250 mg/5ml - active: cefaclor monohydrate 52.45 mg/ml equivalent to cefaclor 50 mg/ml excipient: mannitol simeticone sodium laurilsulfate sorbitol xanthan gum

Jordanië - Engels - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الشرق الاوسط للصناعات الدوائية - middle east pharmaceutical and chemical industries - cefaclor (monohydrate) 500 mg - (monohydrate) 500 mg

Jordanië - Engels - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة الشرق الاوسط للصناعات الدوائية - middle east pharmaceutical and chemical industries - cefaclor (monohydrate) 500 mg - (monohydrate) 500 mg